Buprenorphine Mini-Course: Building on Federal Prescribing Guidance
Presented by the American Society of Addiction Medicine in collaboration with the American Medical Association and Shatterproof
This 1-hour, on-demand module presented by the American Society of Addiction Medicine (ASAM) in collaboration with the American Medical Association (AMA) and Shatterproof provides information and guidance for prescribers seeking to initiate buprenorphine for the treatment of opioid use disorder.
This module expands on the SAMHSA Buprenorphine Quick Start Guide. Utilizing the chronic care framework of addiction treatment, this fully on-demand module offers practical considerations for buprenorphine initiation, dosing, and ongoing patient management. Further, through interactive and application-focused learning, participants will explore the core principles of opioid use disorder treatment and the importance of language when treating patients with this condition.
The target audience for this introductory level activity includes prescribers seeking to initiate buprenorphine for the treatment of opioid use disorder.
This activity addresses the following ACGME Competencies: Patient Care and Procedural Skills, Medical Knowledge, Practice-Based Learning and Improvement, Interpersonal and Communication Skills.
Upon completion, learners will be able to:
- Examine the core principles of opioid use disorder treatment through the chronic disease framework of addiction
- Explore safe buprenorphine prescribing recommendations, guidance, and implementation strategies for new prescribers
- Identify best practices and clinical considerations for buprenorphine initiation, stabilization, dosing, treatment, and discontinuation
- Examine recommendations for ongoing patient management, monitoring, engagement, and care